| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.33B | +3.7% |
| Cost of Revenue | $1.20B | +13.2% |
| Gross Profit | $126.7M | -42.4% |
| R&D Expense | $800K | -52.9% |
| SG&A Expense | $73.8M | -4.4% |
| Interest Expense | $3.9M | -33.9% |
| Pre-tax Income | $97.1M | -45.0% |
| Income Tax | $32.0M | +461.4% |
| Net Income | $65.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $257.2M | -0.9% |
| Accounts Receivable | $79.4M | -21.0% |
| Inventory | $192.4M | -8.8% |
| Current Assets | $556.6M | -4.4% |
| Total Assets | $1.08B | -6.6% |
| Current Liabilities | $186.7M | -25.6% |
| Long-term Debt | $20.4M | -54.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $134.5M | -31.7% |
| Capital Expenditures | $27.1M | +122.1% |
| Investing Cash Flow | -$21.7M | -352.1% |
| Financing Cash Flow | -$114.6M | -224.6% |
| Free Cash Flow | $107.4M | -41.9% |
| -61.9% |
| EPS (Basic) | $1.42 | -61.9% |
| EPS (Diluted) | $1.30 | -59.1% |
| Total Liabilities |
| $395.5M |
| -20.0% |
| Stockholders' Equity | $686.5M | +3.3% |